Coal tar solution 10% / Salicylic acid 6% in Unguentum M cream Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

coal tar solution 10% / salicylic acid 6% in unguentum m cream

special order - coal tar solution; salicylic acid - cream - 100mg/1gram ; 60mg/1gram

Coal tar solution 2% / Salicylic acid 3% in Betamethasone valerate 0.1% cream Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

coal tar solution 2% / salicylic acid 3% in betamethasone valerate 0.1% cream

special order - betamethasone valerate; coal tar solution; salicylic acid - cream - 950microgram/1gram ; 20mg/1gram ; 30mg/1gram

Coco-Scalp Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

coco-scalp

aft pharmaceuticals ltd - coal tar solution 12%{relative};  ;  ; salicylic acid 2%{relative};  ; sulfur 4%{relative};   - topical ointment - 12%w/w, 2%w/w, 4%w/w - active: coal tar solution 12%{relative}     salicylic acid 2%{relative}   sulfur 4%{relative}   excipient: cetostearyl alcohol coconut oil glycerol hard paraffin liquid paraffin macrogol stearate 400 white soft paraffin

TAR POMADE %v/v Ointment Irlandia - angielski - HPRA (Health Products Regulatory Authority)

tar pomade %v/v ointment

foran chemicals ltd - coal tar solution salicylic acid - ointment - %v/v

Clopidogrel/Acetylsalicylic acid Teva Unia Europejska - angielski - EMA (European Medicines Agency)

clopidogrel/acetylsalicylic acid teva

teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinations - clopidogrel/acetylsalicylic acid teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). clopidogrel/acetylsalicylic acid teva is a fixed‑dose combination medicinal product for continuation of therapy in:non‑st segment elevation acute coronary syndrome (unstable angina or non‑q‑wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

Cocois ointment Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

cocois ointment

rph pharmaceuticals ab - coal tar solution; sulfur precipitated; salicylic acid - cutaneous ointment - 120mg/1gram ; 40mg/1gram ; 20mg/1gram

Cocois ointment Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

cocois ointment

sigma pharmaceuticals plc - coal tar solution; sulfur precipitated; salicylic acid - cutaneous ointment - 120mg/1gram ; 40mg/1gram ; 20mg/1gram

Cocois ointment Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

cocois ointment

mawdsley-brooks & company ltd - coal tar solution; sulfur precipitated; salicylic acid - cutaneous ointment - 120mg/1gram ; 40mg/1gram ; 20mg/1gram

Cocois ointment Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

cocois ointment

de pharmaceuticals - coal tar solution; sulfur precipitated; salicylic acid - cutaneous ointment - 120mg/1gram ; 40mg/1gram ; 20mg/1gram

Cocois ointment Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

cocois ointment

waymade healthcare plc - coal tar solution; sulfur precipitated; salicylic acid - cutaneous ointment - 120mg/1gram ; 40mg/1gram ; 20mg/1gram